/BNTC

Benitec Biopharma Inc

BNTC

$12.19USD↓-0.25%-0.03 today

MARKET CAP

418.8M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$12 – $13

52W RANGE

$10

$17

AI Summary

Stalk

Buy NowMedium

The asset remains in a healthy Stage 2 uptrend, supported by a clear HH/HL sequence and active Lockout Rally dynamics. While a Bullish Exhaustion pattern signals momentum fatigue at recent highs, price is now pulling back into rising 9/21 EMAs at structural support, offering an attractive entry for continuation. The Lockout Rally override confirms short-term execution readiness despite overbought readings, and medium-term bullish bias persists within Stage 2, though near-term resistance at the 200 DMA and exhaustion risks warrant caution.

↑80% upside potential as analysts set $24.80 target
↑Q2 EPS loss of $0.24 beats estimates of -$0.27
↓Earnings yield deeply negative, reflecting low return generation

Full analysis →

Buying

6

institutions

Selling

3

institutions

New Positions

1

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
JH Janus Henderson Group Plc Q1 2026	BUY	5.75 M	61.44 M	+2.84 M	+56.4%	0.01%
BI Blackrock, Inc. Q2 2026	BUY	1.41 M	18.83 M	+221.40 K	+49.1%	0.00%
MM Millennium Management LLC Q2 2026	BUY	921.30 K	12.33 M	+269.24 K	+77.5%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	650.50 K	8.70 M	+-3.33 K	+25.0%	0.01%
CA Citadel Advisors LLC Q2 2026	SELL	81.47 K	1.09 M	+-90.26 K	-40.4%	0.00%
AC Adar1 Capital Management, LLC Q2 2026	BUY	40.00 K	535.20 K	+22.50 K	+187.2%	0.02%
AC Aqr Capital Management LLC Q2 2026	BUYNEW	22.48 K	300.80 K	+22.48 K	+0.0%	0.00%
JC Jpmorgan Chase & Co Q2 2026	BUY	9.00 K	114.25 K	+1.11 K	+44.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-16.61 K	-100.0%	0.00%